CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2014;20(1):38-46. Published online 2014 March 26 DOI: https://doi.org/10.3350/cmh.2014.20.1.38

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clinical and Molecular Hepatology. 2014;20(1):38

Link1 Link2

Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients

Steven Herrine

Therapeutics and Clinical Risk Management. 2008;Volume 4:789-796

Link1 Link2

Effectiveness of pegylated interferon/ribavirin combination in ‘real world’ patients with chronic hepatitis C virus infection

G. BORRONI, M. ANDREOLETTI, M. A. CASIRAGHI, R. CERIANI, P. GUERZONI, B. OMAZZI, N. TERRENI, F. SALERNO

Alimentary Pharmacology & Therapeutics. 2008;27(9):790-797

Link1

565 Antifibrogenic effect of combination interferon plus ribavirin treatment in patients with chronic hepatitis C

Journal of Hepatology. 2005;42:206

Link1 Link2

Treatment with amantadine +ribavirin +interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy

Peter Ferenci, Rudolf Stauber, Franz Hackl, Kurt Schuetze, Bernhard Bauer, Christian Datz

Gastroenterology. 2000;118(4):A1437

Link1 Link2

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin

Olav Dalgard

Pharmacogenomics and Personalized Medicine. 2010;1

Link1

Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon and ribavirin: ‘Lead-in or no lead-in’?

Graham R. Foster, Lawrence D. Serfaty

Liver International. 2011;32:61-63

Link1

Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-α and ribavirin combination therapy in patients with chronic hepatitis C virus infection

Tomohide Tatsumi, Tetsuo Takehara, Takuya Miyagi, Shoichi Nakazuru, Eiji Mita, Tatsuya Kanto, Naoki Hiramatsu, Norio Hayashi

Hepatology Research. 2010;41(1):30-38

Link1

A multicenter survey of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

Tsugiko Oze, Naoki Hiramatsu, Eiji Mita, Norio Akuta, Naoya Sakamoto, Hiroaki Nagano, Yoshito Itoh, Shuichi Kaneko, Namiki Izumi, Hideyuki Nomura, Norio Hayashi, Tetsuo Takehara

Hepatology Research. 2013;43(1):35-43

Link1

457 Retreatment with pegylated interferon alpha-2B and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus REG

C. Bapin, P. Fabbro-Peray, S. Hachemane, F. Blanc, D. Diaz, P. Pueyo, D. Larrey

Journal of Hepatology. 2004;40:135

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.